Over the past two decades, extracorporeal membrane oxygenation has undergone a remarkable transformation. Advances in mobility, system integration, and clinical experience have expanded where and how ECMO can be used — changing its role from a highly specialized stationary intervention into a widely applicable form of life-sustaining support in modern critical care.

As the building block to living organisms, cells make up our bodies and perform a wide variety of different functions, all while being the smallest unit of the body. Depending on the tissue type, cells can be more or less specialized.

Single-use manufacturing is the production of a finished product that is designed to be used once. In the biopharmaceutical industry, single-use manufacturing is an important and growing part of the industry.

One of the major technologies introduced to the biotech industry in recent years has been artificial intelligence. Artificial intelligence (AI) is technology that utilizes human patterns and behaviors to mimic their problem solving in order to perform tasks like answering questions or providing relevant information.

Hospitals face rising patient numbers and limited staff. To better manage these pressures, several Danish healthcare facilities implemented INSIGHT.

Venovenous extracorporeal membrane oxygenation (VV-ECMO) has become a vital therapeutic option in managing severe acute respiratory distress syndrome (ARDS) when conventional interventions fail. The American Thoracic Society (ATS) in 2024 and the European Society of Intensive Care Medicine (ESICM) in 2023 released updated guidelines addressing the role of VV-ECMO. This article provides an overview of both guidelines, outlining their common ground and key distinctions without evaluating or favoring one approach over another.

In pharmaceutical production, maintaining equipment uptime is essential for operational efficiency and process safety. Particularly in cleanroom environments, unplanned downtime can disrupt workflows, increase overhead costs, and in some cases contribute to delays in drug availability.

In the ever-evolving landscape of medical technology, ensuring the safety and performance of surgical equipment is paramount. The IEC 60601-2-41:2021 (Edition 3) standard sets forth the particular requirements for the basic safety and essential performance of surgical luminaires and luminaires for diagnosis.

Modern operating rooms are high-stakes environments where every minute counts. An unexpected issue with critical equipment like the operating table can disrupt schedules and even jeopardize patient safety.

During sterile manufacturing, human operators pose the greatest risk for product contamination. To reduce microbiological and particulate contamination risks, aseptic techniques typically rely on either laminar flow equipment used within a cleanroom environment or barrier technology. Laminar flow equipment includes laminar flow hoods and biosafety cabinets (Class I, Class II, and Class III). Barrier technology includes restricted access barrier systems (RABS) and isolators.

Facing the dual challenge of boosting efficiency and reducing strain of staff, a leading sterilization provider in Japan has digitalized their sterile reprocessing.

Explore the future of pharmaceutical manufacturing with 4 key trends in sterile component transfer. From pre-validated solutions to manufacturing flexibility and increased automation, discover how industry leaders ww5 and West are shaping the landscape.